Fairmount Funds Management LLC / COGT
Fairmount Funds Management LLC’s Cogent Biosciences Inc Position
Does Fairmount Funds Management LLC own Cogent Biosciences Inc (COGT)? Yes — 5.50M shares worth $212M (+15.30% of its 13F portfolio) as of Q1 2026, down from 9.00M shares the prior filed quarter.
Position Value
$212M
Q1 2026
Shares
5.50M
% of Portfolio
+15.30%
Quarters Held
22
currently held
Position History COGT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 5.50M | $212M | +15.30% |
| Q4 2025 | 9.00M | $320M | +24.34% |
| Q3 2025 | 9.00M | $129M | +11.63% |
| Q2 2025 | 6.23M | $45M | +5.79% |
| Q1 2025 | 6.23M | $37M | +5.79% |
| Q4 2024 | 6.23M | $49M | +4.83% |
| Q3 2024 | 6.23M | $67M | +5.45% |
| Q2 2024 | 6.23M | $52M | +5.93% |
| Q1 2024 | 4.73M | $32M | +3.46% |
| Q4 2023 | 3.56M | $21M | +2.21% |
| Q3 2023 | 3.56M | $35M | +4.17% |
| Q2 2023 | 3.56M | $42M | +5.94% |
| Q1 2023 | 2.76M | $30M | +5.12% |
| Q4 2022 | 2.76M | $32M | +5.06% |
| Q3 2022 | 2.76M | $41M | +7.24% |
| Q2 2022 | 2.76M | $25M | +5.70% |
| Q1 2022 | 1.56M | $12M | +2.76% |
| Q4 2021 | 1.56M | $13M | +4.41% |
| Q3 2021 | 1.56M | $13M | +4.77% |
| Q2 2021 | 1.56M | $13M | +5.20% |
| Q1 2021 | 1.56M | $14M | +5.77% |
| Q4 2020 | 1.56M | $18M | +6.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fairmount Funds Management LLC’s full portfolio or all institutional holders of COGT.